Polypharmacology of dopamine D1-like receptor antagonists
Drug discovery based on development of selective ligands for a specific target intended to modulate its activity and revert pathophysiological process is now recognized as too simplistic to design effective agent for complex multifactorial diseases, characterized by diverse physiological dysfunction...
Saved in:
Main Authors: | Nikolić Katarina (Author), Filipić Slavica (Author), Agbaba Danica (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists
by: Antonijević Mirjana, et al.
Published: (2017) -
Partial Least Square and Hierarchical Clustering in ADMET Modeling: Prediction of Blood - Brain Barrier Permeation of α-Adrenergic and Imidazoline Receptor Ligands
by: Katarina Nikolic, et al.
Published: (2013) -
3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists
by: Radan Milica, et al.
Published: (2017) -
Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors
by: Richard Ågren, et al.
Published: (2020) -
Modelling of chromatographic and electrophoretic behaviour of imidazoline and alpha adrenergic receptors ligands under different acid-base conditions
by: Slavica Oljacic, et al.
Published: (2024)